CLXClorox Company — stock analysis & sentiment

At $96.73, Clorox trades in the lower half of a 52-week band that runs from $84.70 to $128.90 — closer to the floor than the ceiling, and roughly 25% below the high. That spread is wide for a consumer staples name, meaning the stock has repriced meaningfully over the past year rather than drifting sideways.

The market values the business at about 15.7 times trailing earnings and 16.0 times forward estimates, so expectations for the year ahead sit slightly below where trailing results stand. Net margin is around 11.2%, while revenue growth is essentially flat at 0.1% — profitability is intact even as the top line holds still. The dividend yield of 5.13% is elevated relative to the stock's own history of price levels, a function of the payout being measured against a share price near the low end of its range. Beta of 0.53 indicates the shares have moved at roughly half the amplitude of the broader market. Price-to-book is negative, which reflects a balance sheet where liabilities exceed book equity — common for mature consumer companies that have carried out sustained buybacks — and makes that particular ratio uninformative here.

Recent coverage has been dominated by dividend-focused commentary rather than company-specific events. Headlines through June and July 2026 group Clorox with other long-running dividend payers, including one noting stocks that recently touched 52-week lows and another framing dividend names as a hedge if the AI trade cools. Two late-May pieces compared Clorox directly against Kimberly-Clark and Procter & Gamble, placing it within a broader consumer goods peer discussion. Little of the flow concerns operational developments at the company itself.